These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8046974)

  • 21. [The effect of diltiazem in the patients with pulmonary hypertension].
    Tomita N; Hamada M; Kazatani Y; Shigematsu Y; Sueda S; Sekiya M; Ochi T; Ito T; Kokubu T; Kukita H
    Kokyu To Junkan; 1985 Oct; 33(10):1257-64. PubMed ID: 4081356
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O; Humbert M; Jaïs X; Ioos V; Hamid AM; Provencher S; Garcia G; Parent F; Hervé P; Simonneau G
    Circulation; 2005 Jun; 111(23):3105-11. PubMed ID: 15939821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
    Bühler G; Wadepuhl M; Nandi K; Rosenthal J
    Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical & surgical approaches to pulmonary hypertension.
    McLaughlin VV; Rich S
    Compr Ther; 1997 Sep; 23(9):612-6. PubMed ID: 9285162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged QT interval and ventricular fibrillation after treatment with sublingual nifedipine for malignant hypertension.
    Peters FP; de Zwaan C; Kho L
    Arch Intern Med; 1997 Dec 8-22; 157(22):2665-6. PubMed ID: 9531240
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium channel blockers induce thymic apoptosis in vivo in rats.
    Balakumaran A; Campbell GA; Moslen MT
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):122-7. PubMed ID: 8685894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Verapamil (an antagonist of calcium) and its effect on chronic pulmonary hypertension in humans].
    Widimský J; Jandová R; Frídl P; Ostádal B
    Cas Lek Cesk; 1982 Jun; 121(25):775-8. PubMed ID: 7116382
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcium antagonist verapamil prevented pulmonary arterial hypertension in broilers with ascites by arresting pulmonary vascular remodeling.
    Yang Y; Qiao J; Wang H; Gao M; Ou D; Zhang J; Sun M; Yang X; Zhang X; Guo Y
    Eur J Pharmacol; 2007 Apr; 561(1-3):137-43. PubMed ID: 17320074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Attempted suicide with oral diltiazem].
    Sevilla F; Arruego MA; Monzón FJ; Boix L
    Med Clin (Barc); 1996 Sep; 107(7):275. PubMed ID: 8975098
    [No Abstract]   [Full Text] [Related]  

  • 31. [Levels of malonyl dialdehyde and vitamin A in blood serum after administration of therapeutic doses of nifedipine].
    Misiewicz A; Sieradzka I; Dziewit T; Radwan K; Dutkiewicz B; Szota M
    Wiad Lek; 1998; 51(3-4):151-5. PubMed ID: 9658989
    [No Abstract]   [Full Text] [Related]  

  • 32. [Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation].
    Pimenov LT; Ezhov AV; Churshin AD
    Klin Med (Mosk); 1995; 73(5):69-71. PubMed ID: 8815289
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of nifedipine on serum endothelin-1 levels in essential hypertension.
    Akpolat T; Başkol M; Adam B; Arik N; Bedir A
    Clin Nephrol; 1997 Feb; 47(2):130-1. PubMed ID: 9049464
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV-associated pulmonary hypertension.
    Farber HW
    AIDS Clin Care; 2001 Jun; 13(6):53-5, 59. PubMed ID: 11710309
    [No Abstract]   [Full Text] [Related]  

  • 35. [Primary pulmonary hypertension: new treatment options].
    Madan S; Boonstra A; Berger RM
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1836-42. PubMed ID: 11593786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Calcium antagonists--much noise about nothing?].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1995 Dec; 18(12):344-9. PubMed ID: 8569586
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease.
    Franz IW; Van Der Meyden J; Schaupp S; Tönnesmann U
    Z Kardiol; 2002 Oct; 91(10):833-9. PubMed ID: 12395224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nifedipine trials.
    Rafflenbeul W
    Circulation; 1996 Apr; 93(7):1473-4. PubMed ID: 8641042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.